scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1035771346 |
P356 | DOI | 10.1186/1476-4598-9-129 |
P932 | PMC publication ID | 2890609 |
P698 | PubMed publication ID | 20509882 |
P5875 | ResearchGate publication ID | 44637402 |
P50 | author | Cestmir Altaner | Q55299637 |
P2093 | author name string | Kristina Hlubinova | |
Veronika Altanerova | |||
Lucia Kucerova | |||
Miroslava Matuskova | |||
P2860 | cites work | Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model | Q39998770 |
Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling | Q40002631 | ||
Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells | Q40018816 | ||
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy | Q40110233 | ||
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. | Q40195961 | ||
Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells | Q40216419 | ||
Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). | Q40298054 | ||
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging | Q40353003 | ||
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo | Q40363908 | ||
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 | ||
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling | Q47620825 | ||
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. | Q50685836 | ||
Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. | Q51492530 | ||
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma | Q62019424 | ||
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study | Q80471824 | ||
In search of the in vivo identity of mesenchymal stem cells | Q81485769 | ||
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
Cancer-related inflammation | Q27860907 | ||
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. | Q28274091 | ||
Microenvironmental regulation of metastasis | Q29547660 | ||
Mesenchymal stem cells in health and disease | Q29614296 | ||
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression | Q33427809 | ||
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor | Q33879286 | ||
Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts | Q35977847 | ||
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma | Q36238078 | ||
Tumor microenvironment: the role of the tumor stroma in cancer | Q36709404 | ||
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells | Q36709408 | ||
The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles | Q36842444 | ||
The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy | Q36897375 | ||
Immunomodulation by mesenchymal stem cells and clinical experience | Q36975987 | ||
Cancer stem cells in solid tumors | Q37006419 | ||
Concise review: adult multipotent stromal cells and cancer: risk or benefit? | Q37128260 | ||
Mesenchymal stem cells in cancer | Q37169180 | ||
Tumor dormancy due to failure of angiogenesis: role of the microenvironment | Q37194667 | ||
Concise review: mesenchymal stromal cells: potential for cardiovascular repair. | Q37206855 | ||
The mesenchymal stromal cell contribution to homeostasis | Q37211949 | ||
Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells | Q37233572 | ||
Molecular characterisation of the tumour microenvironment in breast cancer | Q37312142 | ||
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo | Q37657276 | ||
Chemokines and chemokine receptors: new insights into cancer-related inflammation. | Q37694068 | ||
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment | Q39727653 | ||
HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells | Q39797615 | ||
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. | Q39923052 | ||
Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. | Q39955301 | ||
Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo | Q39975853 | ||
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 | ||
P304 | page(s) | 129 | |
P577 | publication date | 2010-05-28 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | Tumor cell behaviour modulation by mesenchymal stromal cells | |
P478 | volume | 9 |
Q92543310 | A Bifunctional Molecule with Lectin and Protease Inhibitor Activities Isolated from Crataeva tapia Bark Significantly Affects Cocultures of Mesenchymal Stem Cells and Glioblastoma Cells |
Q90290608 | A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells |
Q27002515 | A role for G-CSF and GM-CSF in nonmyeloid cancers |
Q26849284 | Adipose tissue stem cells: the great WAT hope |
Q39505071 | Alginate encapsulated human mesenchymal stem cells suppress syngeneic glioma growth in the immunocompetent rat. |
Q35037638 | Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells |
Q35091885 | Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results |
Q90398769 | Anti-tumor effects of engineered mesenchymal stem cells in colon cancer model |
Q53508987 | Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats. |
Q47122926 | CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma |
Q28541524 | Can we negotiate with a tumor? |
Q38226664 | Cells as delivery vehicles for cancer therapeutics |
Q36454593 | Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells |
Q52936462 | Commentary on: Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Head and Neck Cancer Xenografts. |
Q47104412 | Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development. |
Q50012087 | Contrasting Views on the Role of Mesenchymal Stromal/Stem Cells in Tumour Growth: A Systematic Review of Experimental Design |
Q89170832 | Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment |
Q38925583 | Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. |
Q38243325 | Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth |
Q47552057 | Effects of rat bone marrow-derived mesenchymal stem cells on breast cancer cells with differing hormone receptor status |
Q39244769 | Gene expression profiles of various cytokines in mesenchymal stem cells derived from umbilical cord tissue and bone marrow following infection with human cytomegalovirus |
Q38910173 | Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft |
Q38696750 | Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer |
Q58554616 | Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms |
Q28075643 | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
Q39512141 | Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma |
Q48019368 | Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation. |
Q45338034 | Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia |
Q37050899 | Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice |
Q39354315 | Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma |
Q38806320 | Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects |
Q47611481 | Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model. |
Q98467261 | Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy |
Q47868876 | Inhibition of neuropathic hyperalgesia by intrathecal bone marrow stromal cells is associated with alteration of multiple soluble factors in cerebrospinal fluid. |
Q38972307 | Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model |
Q38080971 | Mesenchymal autologous stem cells |
Q42039139 | Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells |
Q64968938 | Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism. |
Q55379731 | Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms. |
Q33728678 | Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival |
Q47107479 | Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NF-κB signaling by paracrine CCL5. |
Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
Q34638665 | Mesenchymal stem cells in tissue growth and repair |
Q38032086 | Mesenchymal stem cells in tumor development: emerging roles and concepts |
Q38780560 | Mesenchymal stem cells: From stem cells to sarcomas |
Q35125560 | Mesenchymal stem cells: angels or demons? |
Q35240668 | Mesenchymal stem cells: from experiment to clinic |
Q39113929 | Mesenchymal stem cells: key players in cancer progression |
Q90012585 | Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression |
Q41979143 | Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β |
Q39215411 | Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice |
Q102141808 | Mitochondrial oxidative phosphorylation in cutaneous melanoma |
Q35553117 | Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy |
Q37975113 | Multipotent mesenchymal stromal cell therapy and risk of malignancies |
Q38761193 | Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth |
Q52956451 | Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells. |
Q52097023 | Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. |
Q35540034 | Potential of Mesenchymal Stem Cell based application in Cancer |
Q64079002 | Pre-clinical Models for Studying the Interaction Between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness |
Q64100317 | Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer |
Q34447802 | Regenerative therapy after cancer: what are the risks? |
Q33997951 | Stem cell based gene therapy in prostate cancer |
Q39454392 | Stem cell therapy in osteoarthritis: a step too far? |
Q26745894 | Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types |
Q28074203 | The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells |
Q64241117 | The Different Effects of IFN-β and IFN-γ on the Tumor-Suppressive Activity of Human Amniotic Fluid-Derived Mesenchymal Stem Cells |
Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
Q42000888 | The dual role of mesenchymal stem cells in tumor progression. |
Q35440270 | The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: a role for the secreted frizzled-related proteins |
Q58610756 | The role of tumour microenvironment: a new vision for cholangiocarcinoma |
Q39143427 | Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. |
Q41402133 | Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells |
Q40739842 | Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment |
Search more.